APC: Braking neutrophils to benefit patients?

Blood

Volumn 104, Issue 13, 2004, Pages 3841-

  Mizgerd, Joseph P ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C;

DISEASE SEVERITY; DOSE RESPONSE; HOST RESISTANCE; HUMAN; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REVIEW; SEPSIS; SURVIVAL TIME;

EID: 19744376844     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-09-3628     Document Type: Review

References (2)

1. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med. 2001;344:699-709.
2. Sturn DH, Kaneider NC, Fetstritzer C, Djanani A, Fukudome K, Wiedermann CJ. Expression and function of the endothelial protein C receptor in human neutrophils. Blood. 2003;102:1499-1505.